EURICAN DAP-LMULTI LYOPHILISATE AND SUSPENSION FOR SUSPENSION FOR INJECTION
EURICAN DAP-LMULTI LYOPHILISATE AND SUSPENSION FOR SUSPENSION FOR INJECTION
Not authorised
- Leptospira interrogans, serogroup Canicola, serovar Canicola, strain 16070, Inactivated
- Canine adenovirus 2, strain DK13, Live
- Canine distemper virus, strain BA5, Live
- Canine parvovirus, strain CAG2, Live
- Leptospira interrogans, serogroup Grippotyphosa, serovar Grippotyphosa, strain Grippo Mal 1540, Inactivated
- Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain 16069, Inactivated
Product identification
Medicine name:
EURICAN DAP-LMULTI LYOPHILISATE AND SUSPENSION FOR SUSPENSION FOR INJECTION
Eurican DAP-Lmulti, süstesuspensiooni lüofilisaat ja suspensioon
Active substance:
- Leptospira interrogans, serogroup Canicola, serovar Canicola, strain 16070, Inactivated
- Canine adenovirus 2, strain DK13, Live
- Canine distemper virus, strain BA5, Live
- Canine parvovirus, strain CAG2, Live
- Leptospira interrogans, serogroup Grippotyphosa, serovar Grippotyphosa, strain Grippo Mal 1540, Inactivated
- Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain 16069, Inactivated
Target species:
-
Dog
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Leptospira interrogans, serogroup Canicola, serovar Canicola, strain 16070, Inactivated1.00/Hamster protective Dose 80 % (Ph. Eur. Monograph)1.00Dose
-
Canine adenovirus 2, strain DK13, Live316.23/tissue culture infective dose 501.00Dose
-
Canine distemper virus, strain BA5, Live10000.00/tissue culture infective dose 501.00Dose
-
Canine parvovirus, strain CAG2, Live79432.80/tissue culture infective dose 501.00Dose
-
Leptospira interrogans, serogroup Grippotyphosa, serovar Grippotyphosa, strain Grippo Mal 1540, Inactivated1.00/Hamster protective Dose 80 % (Ph. Eur. Monograph)1.00Dose
-
Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain 16069, Inactivated1.00/Hamster protective Dose 80 % (Ph. Eur. Monograph)1.00Dose
Pharmaceutical form:
-
Lyophilisate and suspension for suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
- Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AI03
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Estonia
Package description:
- Plastic box of 25 vials (glass) of lyophilisate (1 dose) and 25 vials (glass) of suspension (1 ml)
- Plastic box of 50 vials (glass) of lyophilisate (1 dose) and 50 vials (glass) of suspension (1 ml)
- Plastic box of 10 vials (glass) of lyophilisate (1 dose) and 10 vials (glass) of suspension (1 ml)
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - New active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
- Boehringer Ingelheim Animal Health France
Responsible authority:
- State Agency Of Medicines
Authorisation number:
- 1936
Date of authorisation status change:
Reference member state:
-
France
Procedure number:
- FR/V/0287/001/DC
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Estonian (PDF)
Published on: 6/06/2022
How useful was this page?:
